News

  • AIM Coalition Welcomes Health Affairs Study on Urologist “Self-Referral” of Surgical Pathology Services

    April 10, 2012
      Study by Georgetown’s Jean Mitchell says self-referral is increasing billings for prostate biopsy pathology evaluations, but not improving cancer detection Washington DC – The Alliance for Integrity in Medicare (AIM)—a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups—today applauded publication of a new study which focuses on the practice of self-referral among urologists who conduct prostate biopsy evaluations inContinue Reading »...
  • New Study On Self-Referral Labs: More Tests, Higher Costs, Fewer Cancer Detections

    April 09, 2012
     CAP Urges Immediate Action to Close In-office Loophole in Federal Law NORTHFIELD, Ill. — A new study by researchers at Georgetown University reveals that the practice of ordering tests from pathology labs in which treating physicians have a financial stake resulted in increased utilization, higher Medicare spending, and lower rates of cancer detection. The independent study was published today in Health Affairs and ledContinue Reading »...
  • ACLA Lauds New Health Affairs Study Finding Medicare Costs Rise and Fewer Cancers Are Detected When Physicians Self-Refer for Prostate Cancer Surgical Pathology Services

    April 09, 2012
    Study demonstrates physicians’ financial self-interest may drive unwarranted procedures and unnecessary Medicare spending; highlights the need for Congress to end legal loophole permitting self-referral of surgical pathology services. Washington, DC – The American Clinical Laboratory Association (ACLA) today welcomed a new study published in Health Affairs providing compelling evidence of the increase in government health care spending that results from urologists performing prostate biopsiesContinue Reading »...
  • Comments Regarding Appropriate Use of Clinical Laboratory Testing

    April 04, 2012
      April 4, 2012 ACLA Comments on Choosing Wisely and Appropriate Use of Clinical Laboratory Testing Statement: The American Clinical Laboratory Association welcomes the Choosing Wisely effort and is now reviewing the report. We applaud continued efforts by physicians and medical groups to bring their expertise and evidence to bear in the effort to encourage appropriate utilization of medical testing. We note that mostContinue Reading »...
  • Letter to HHS on ICD-10 Implementation

    March 28, 2012
    March 28, 2012 The Honorable Kathleen Sebelius Secretary Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue, S.W. Washington, DC 20201 Re: ICD-10-CM Implementation Dear Secretary Sebelius, I am writing to you on behalf of the American Clinical Laboratory Association (ACLA) to urge the Department of Health and Human Services (HHS) to adopt several important recommendations as theContinue Reading »...
  • Letter to Reps Kind and Price Regarding Health Information Technology Reform Act

    March 14, 2012
      March 14, 2012 The Honorable Ron Kind 1406 Longworth House Office Building Washington, DC 20515 The Honorable Tom Price 403 Cannon House Office Building Washington, DC 20515 Dear Congressmen Kind and Price: On behalf of the American Clinical Laboratory Association (ACLA), I am writing in support of the Health Information Technology Reform Act, HR 4066, which seeks to exclude pathologists from incentive paymentsContinue Reading »...
  • Letter to Speaker Boehner and Majority Leader Reid Regarding Medicare Clinical Laboratory Fee Schedule

    March 06, 2012
      March 6, 2012 The Honorable John A. Boehner Speaker U.S. House of Representatives H-232, The Capitol Washington, DC 20515 The Honorable Harry Reid Majority Leader U.S. Senate S-221, The Capitol Washington, DC 20510 Dear Speaker Boehner and Leader Reid: I am writing you today on behalf of the American Clinical Laboratory Association (ACLA), which represents the leading national, regional, esoteric, and pathology clinicalContinue Reading »...
  • Big Cuts in Reimbursement for Medicare Lab Tests will Hurt Patients, says ACLA

    March 06, 2012
      Cumulative cuts from recently enacted legislation total 23% over next 10 years Washington, DC — Recently enacted budget cuts that would slash Medicare reimbursement for clinical laboratory tests by 23% over the next 10 years threaten the ability of clinical labs to serve Medicare patients, according to a letter that the American Clinical Laboratory Association sent today to House Speaker John Boehner andContinue Reading »...
  • Comments Regarding Sunshine Rule

    February 17, 2012
      February 17, 2012 Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS—5060—-P Mail Stop C4—26—05 7500 Security Boulevard Baltimore, MD 21244-1850 RE: CMS-5060-P Transparency Reports and Reporting of Physician Ownership or Investment Interests Dear Acting Administrator Tavenner: The American Clinical Laboratory Association (ACLA) appreciates the opportunity to provide comments to the Centers for Medicare & Medicaid Services (CMS)Continue Reading »...
  • Comments on Coverage with Evidence Development

    January 18, 2012
      January 18, 2012 Louis Jacques, MD Director, Coverage and Analysis Group Office of Clinical Standards Quality Centers for Medicare and Medicaid Services 7500 Security Blvd Baltimore, Maryland 21244 RE: Coverage with Evidence Development (CED) Public Comment & Solicitation Dear Dr. Jacques, The American Clinical Laboratory Association (“ACLA”) is pleased to have this opportunity to submit comments to the Centers for Medicare and MedicaidContinue Reading »...